A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer

British Journal of Cancer

Volumn 89, Issue 8, 2003, Pages 1428-1432

  Graziano, F ^a   Santini, D ^b   Testa, E ^a   Catalano, V ^c   Beretta, G D ^d   Mosconi, S ^d   Tonini, G ^b   Lai, V ^a   Labianca, R ^d   Cascinu, S ^e  

^a Hospital of Urbino   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d Hospital of Bergamo   (Italy)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Chemotherapy; Elderly; Gastric cancer; Phase II; Weekly

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CISPLATIN; FLUOROURACIL; FOLINIC ACID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; SEROTONIN 3 ANTAGONIST;

ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; GASTRECTOMY; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COST CONTROL; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; FEMALE; FILGRASTIM; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0242575737     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601280     Document Type: Article

References (29)

1. Balducci L, Beghe C (1999) Pharmacology of chemotherapy in the older cancer patient. Cancer Control 6: 466-470
2. Balducci L, Beghe C (2000) The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 35: 147-154
3. Balducci L, Yates J (2000) General guidelines for management of older patients with cancer. Oncology 14: 221-227
4. Cascinu G, Catalano G (1995) Intensive weekly chemotherapy for elderly gastric cancer patients using 5-fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin and gluthatione with the support of G-CSF. Tumori 81: 32-35
5. Cascinu S, Fedeli A, Catalano G (1994) Etoposide, leucovorin 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study. Cancer Chemother Pharmacol 34: 72-74
6. Cascinu S, Graziano F, Barni S, Labianca R, Comella G, Casaretti R, Frontini L, Catalano V, Baldelli AM, Catalano G (2001) A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer. Br J Cancer 84: 470-474
7. Cascinu S, Labianca R, Alessandroni P, Marcellini M, Silva RR, Pancera G, Testa E, Martignoni G, Barni S, Frontini L, Zaniboni A, Luporini G, Cellerino R, Catalano G (1997) Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, gluthatione and filgrastim: a report of the Italian Group for the Study of the Digestive Tract Cancer. J Clin Oncol 15: 3313-3319
8. Cascinu S, Labianca R, Graziano F, Pancera G, Barni S, Frontini L, Luporini G, Cellerino R, Catalano G (1998) Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, gluthatione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer 78: 390-393
9. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
10. Di Bartolomeo M, Bajetta E, de Braud F, Bochicchio AM, Gebbia V, Bozzetti F, Doci R, Bonfanti G, Cozzaglio L (1995) Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology 52: 41-44
11. Goodwin JS, Samet JM, Hunt WC (1996) Determinants of survival in older cancer patients. J Natl Cancer Inst 88: 1031-1038
12. Graziano F, Santini D, Catalano V, Testa E, Tonini G, Lai V, Baldelli AM, Cascinu S (2002) Weekly cisplatin, fluorouracil and folinic acid as first-line chemotherapy for elderly patients with advanced gastric cancer (AGC). Proc Am Soc Clin Oncol 21: 372 (abstr 1484)
13. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50: 7-33
14. Hartung G, Hofheinz R, Buchheidt D, Rost A, Brecht A, Forche K, Schroder M, Wojatschek C, Fritze D, Hehlmann R, Queisser W. (2000) Combination of bolus 5-fluorouracil, folinic acid and mitomycin-C in advanced gastric cancer: results of a phase II trial. Onkologie 23: 444-447
15. Hill ME, Cunningham D (1998) Medical management of advanced gastric cancer. Cancer Treat Rev 24: 113-118
16. Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341: 2061-2067
17. Ikeda N, Shimada Y, Ohtsu A, Boku N, Tsuji Y, Saito H, Koizumi W, Iwase H, Yoshida S, Fukuda H (2002) A phase II study of doxifluridine in elderly patients with advanced gastric cancer: the Japan Clinical Oncology Group study (JCOG 9410). Jpn J Clin Oncol 32: 90-94
18. Ingram SS, Seo PH, Martell RE, Clipp EC, Doyle ME, Montana GS, Cohen HJ (2002) Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 20: 770-7705
19. Janunger KG, Hafstrom L, Nygren P, Glimelius B, Swedish Council of Technology Assessment in Health Care (2001) A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40: 309-326
20. National Cancer Institute Common Toxicity Criteria (1998), Version 2.0. January 30, 1998. http://ctep.info.nih.gov/CTC3/ctc.htm.0
21. Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, Parodi S, Dal Lago D, Gioia F, Monfardini S, Aapro MS, Serraino D, Zagonel V (2002) Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 20: 494-502
22. Reuben DB (1997) Geriatric assessment in oncology. Cancer 80: 1311-1316
23. Scott WK, Macera CA, Cornman CB, Sharpe PA (1997) Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 50: 291-296
24. Simon R (1989) Optimal two-stage designes for phase II clinical trials. Controlled Clin Trials 10: 1-10
25. Tebbutt NC, Norman A, Cunningham D, Iveson T, Seymour M, Hickish T, Harper P, Maisey N, Mochlinski K, Prior Y, Hill M (2002) A multicentre, randomized phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer. Ann Oncol 13: 1568-1575
26. Wilke H, Preusser P, Fink U, Achterrath W, Lenaz L, Stahl M, Schober C, Link H, Meyer HJ, Lucke B (1990) High dose folinic acid/etoposide/ 5-fluorouracil in advanced gastric cancer: a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 8: 65-70
27. Wils J (1998) Treatment of gastric cancer. Curr Opin Oncol 10: 357-361
28. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underhill C, Wardley A, Meehan M (1997) Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 15: 261-267
29. World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva: World Health Organization